Revisiting the role of eotaxin-1/CCL11 in psychiatric disorders

• Autor(a) principal: Teixeira, Antônio Lúcio
• Data de Publicação: 2018
• Outros Autores: Gama, Clarissa Severino, Rocha, Natalia Pessoa, Teixeira, Mauro Martins
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/182092
• topic: Esquizofrenia; Transtorno bipolar; Envelhecimento; Doença de Alzheimer; Quimiocina CCL11; Eotaxin-1; CCL11; schizophrenia; bipolar disorder; depression; aging; Alzheimer’s disease

Eotaxin-1/CCL11 is a chemokine originally implicated in the selective recruitment of eosinophils into inflammatory sites during allergic reactions, being thoroughly investigated in asthma, allergic rhinitis, and other eosinophil-related conditions. Eotaxin-1/CCL11 is also involved with a skewed immune response toward a type-2 (Th2) profile. In addition to its role in immune response, recent studies have shown that eotaxin-1/CCL11 is associated with aging, neurogenesis and neurodegeneration, being able to influence neural progenitor cells, and microglia. Increased circulating levels of eotaxin-1/CCL11 have been described in major psychiatric disorders (schizophrenia, bipolar disorder, major depression), sometimes correlating with the severity of psychopathological and cognitive parameters. As similar findings have been reported in neurodegenerative conditions such as Alzheimer’s disease, it has been hypothesized that mechanisms involving eotaxin-1/CCL11 signaling may underlie the “accelerated aging” profile commonly linked to psychiatric disorders. Future studies must determine whether eotaxin-1/CCL11 can be regarded as a prognostic biomarker and/or as therapeutic target for resistant/progressive cases.